Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 204

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Current Status of Metals as Therapeutic Targets in Alzheimer's Disease

Finefrock, Anne E., Bush, Ashley I., Doraiswamy, P. Murali·2003·Journal of the American Geriatrics Society

Abstract

There is accumulating evidence that interactions between β‐amyloid and copper, iron, and zinc are associated with the pathophysiology of Alzheimer's disease (AD). A significant dyshomeostasis of copper, iron, and zinc has been detected, and the mismanagement of these metals induces β‐amyloid precipitation and neurotoxicity. Chelating agents offer a potential therapeutic solution to the neurotoxicity induced by copper and iron dyshomeostasis. Currently, the copper and zinc chelating agent clioquinol represents a potential therapeutic route that may not only inhibit β‐amyloid neurotoxicity, but may also reverse the accumulation of neocortical β‐amyloid. A Phase II double‐blind clinical trial of clioquinol with B 12 supplementation will be published soon, and the results are promising. This article summarizes the role of transition metals in amyloidgenesis and reviews the potential promise of chelation therapy as a treatment for AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1532-5415.2003.51368.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

Metadata

Authors
Finefrock, A. E., Bush, A. I., & Doraiswamy, P. M.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2003-07-31
Volume
51
Issue
8
Pages
1143-1148
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2076976809
Cited by
204
References
10
FWCI
7.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current Status of Metals as Therapeutic Targets in Alzheimer's Disease. https://app.cochat.ai/papers/10.1046/j.1532-5415.2003.51368.x
The paper
Finefrock, A. E., Bush, A. I., & Doraiswamy, P. M. (2003). Current Status of Metals as Therapeutic Targets in Alzheimer's Disease. Journal of the American Geriatrics Society. https://doi.org/10.1046/j.1532-5415.2003.51368.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.